HIGHLIGHTS
- who: POSTER PRESENTATION and collaborators from the in Turkey have published the article: PReS-FINAL-2218: Treatment of colchicines resistant FMF: experience of a pediatric center in Turkey, in the Journal: (JOURNAL)
- what: Anti IL1 treatment is beneficial in FMF patients who are resistant to colchicine and can be used safely.
SUMMARY
Familial Mediterrenean fever (FMF) is an autoinflammmatory disorder which result from mutations in MEFV gene and characterized by dysregulated inflammasome activation and IL1b secretion. At least 5% of FMF patients do not respond to colchicine. Objectives To evaluate the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.